JELD-WEN Holding announced CFO Samantha L. Stoddard will resign effective November 13, 2026, to pursue opportunities outside the building products industry. Jeffrey Embt, VP and Chief Accounting Officer, will serve as interim CFO while the company searches for a permanent replacement. Despite the leadership change, JELD-WEN reaffirmed its 2026 financial guidance, expecting revenues of $3.1-$3.2 billion and Adjusted EBITDA of $120-$150 million. The transition reflects a strategic move to maintain financial stability and continue executing company priorities.
JELD-WEN's CFO transition is noted here with Consumer Cyclical sector data for context. For readers following Consumer Cyclical stocks, of 134 priced US stocks tradable on Pluang, 53 rose and 80 fell today. Notable movers include BBY at USD 93.99 (+5.49%), SE at USD 88.68 (-5.43%) with 77% buy order activity, and AMZN at USD 262.50 (+5.00%) with 76% sell order activity. This snapshot is as of Oct 20, 2026 03:02 WIB.
XBiotech announced positive final efficacy results from its phase II TASKIN trial for vilamakitug (XB2001) in refractory metastatic colorectal cancer. The study, funded by the French National Cancer Institute, showed a 61.3% overall survival rate at ...
XBiotech announced positive final results from the Phase II TASKIN study, showing that adding Vilamakitug (XB2001) to standard chemotherapy improved 12-month overall survival to 61.3% in patients with refractory metastatic colorectal cancer, surpassi...
Dorchester Minerals, L.P. has agreed to acquire mineral and royalty interests covering about 4,300 net royalty acres in three counties within North Dakota's Williston Basin. The deal involves a non-taxable contribution and exchange agreement with an ...
The Hershey Trust Company sold 1,512 common shares under a trading plan but kept voting control through Class B shares. Hershey will report Q3 earnings on October 29, with investors focused on how price increases affected Halloween-season demand. Q2 ...
W. R. Berkley reported mixed Q3 2026 results with earnings per share of $1.17 beating estimates, but revenue fell short at $3.74 billion versus $3.82 billion expected. The company saw premium growth with gross premiums up 3% and net premiums up 1%, s...
